Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
A Phase 1 trial to assess the single-dose safety, tolerability, and pharmacokinetic (PK) of
Methylene Blue Injection, USP 1 mg/kg in healthy adult voluneetrs.